IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Evonik Hones Pharma Focus with Sale of U.K. Unit

10:26 AM MST | December 15, 2008 | Alex Scott

Evonik says the recent sale of its Seal Sands, U.K. fine chemical facility and the planned introduction in the next few weeks of a pharmaceutical ingredient facility at Nanning, China will “significantly” increase its active pharma ingredient (API) production capacity while reducing its exposure to potentially lower-value non-GMP material production. Also, the Seal Sands divestment was made without the Evonik group losing any chemistries, Rudolf Hanko, head of Evonik’s Exclusive Synthesis & Amino Acids business line, tells CW. Evonik...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa